colchicine has been researched along with Coronary Artery Disease in 108 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (1.85) | 18.2507 |
| 2000's | 1 (0.93) | 29.6817 |
| 2010's | 14 (12.96) | 24.3611 |
| 2020's | 91 (84.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bax, WA; Cornel, JH; de Kleijn, DPV; Dekker, M; Duyvendak, M; Fiolet, ATL; Mosterd, A; Opstal, TSJ; Silvis, MJM; Suquilanda, D; The, SHK; Timmers, L; Zivkovic, M | 1 |
| Bouabdallaoui, N; Tardif, JC | 2 |
| Büyükulaş, C; Karahan, E; Polat, YO; Şen, S; Üresin, AY | 1 |
| Budhathoki, P; Elgendy, I; Khadka, M; Mir, WAY; Patel, NK; Patel, T; Pokharel, S; Sedhai, Y; Shrestha, DB; Yadav, S | 1 |
| Dawson, LP; Layland, J; Lum, M; Nerleker, N; Nicholls, SJ | 1 |
| Aw, KL; De Palma, R; Koh, A; Kudzinskas, A; Lee, HL | 1 |
| Lin, Z; Liu, H; Mao, L; Xu, H; Yang, J; Zhang, Y | 1 |
| He, QZ; Little, PJ; Qin, CH; Weng, JP; Xu, SW; Zhang, FS | 1 |
| Agnello, F; Capodanno, D | 1 |
| Huang, D; Liang, H | 1 |
| Chen, Y; Fu, Y; Jiang, Y; Li, M; Liu, Y; Luo, W; Wu, Y; Xia, H; Xu, C; Zhang, H | 1 |
| Bartels, L; Bax, WA; Budgeon, CA; Cornel, JH; de Nooijer, R; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; van Broekhoven, A | 1 |
| Adeva-Andany, MM; Carneiro-Freire, N; Castro-Quintela, E; Fernández-Fernández, C; González-Lucán, M; Vila-Altesor, M | 1 |
| Anastasiou, A; Iliopoulos, DC; Siasos, G; Spartalis, E; Spartalis, M; Tzima, I | 1 |
| Layland, J; Nidorf, SM; Patel, S; Psaltis, PJ; Robinson, PC; Thompson, PL | 1 |
| Chan, BPL; Goh, CXY; Goh, S; Ho, AFW; Ho, JSY; Leow, AST; Sharma, VK; Tan, BYQ; Tan, CH; Tan, NHW; Tan, YK; Yeo, LLL | 1 |
| Chen, L; Cheng, J; Pan, Z; Wang, J; Yang, W | 1 |
| Chen, ZW; Dai, CF; Liu, MY; Qian, JY | 1 |
| Jiang, W; Song, X; Tian, J; Yong, J; Zhang, H; Zhao, X | 1 |
| Conway, S; Griffin, L; Groce, J | 1 |
| Amin, G; Booz, GW; Fares, S; Massoud, G; Zouein, FA | 1 |
| Bax, WA; Budgeon, CA; Byrnes, E; Cornel, JH; de Kleijn, DPV; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Los, J; Mohammadnia, N; Mosterd, A; Nidorf, SM; Opstal, TSJ; Silvis, MJM; Thompson, PL; Tijssen, JGP; van Broekhoven, A | 1 |
| Abu Fanne, R; Arbel, Y; Banai, S; Chorin, E; Groisman, GM; Higazi, AA; Maraga, E | 1 |
| Jammoul, N; Mercier, G; Roubille, F | 1 |
| Alam, M; Jhamnani, S; Jhaveri, A; Kontopantelis, E; Mamas, MA; Savinova, OV; Siddiqui, E | 1 |
| Incedere, F; Kavgacı, A; Kula, S; Terlemez, S | 1 |
| Hao, J; Mu, Y; Tan, L; Wang, S | 1 |
| Chen, T; Liu, G; Yu, B | 1 |
| Nidorf, SM | 2 |
| Abbate, A; Moroni, F | 1 |
| Fuster, V; Nelson, K; Ridker, PM | 1 |
| Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Schut, A; Thompson, PL; Tijssen, JGP | 1 |
| Georgakis, MK; Giannopoulos, S; Katsanos, AH; Kelly, PJ; Kosmidou, M; Lemmens, R; Palaiodimou, L; Price, C; Tsivgoulis, G; Weimar, C | 1 |
| Andersen, ML; Finsterer, J; Oliveira, LF; Rodrigues, LD; Scorza, CA; Scorza, FA; Tufik, S | 1 |
| Abbasi, J | 1 |
| Chan, JSK | 1 |
| Caso, V; Mas, JL | 1 |
| Cronstein, B; Feit, F; Katz, SD; Keller, NM; Lorin, JD; Pillinger, M; Ratnapala, N; Shah, B; Smilowitz, NR; Xia, Y; Zhong, H | 1 |
| Cao, D; Chiarito, M; Mehran, R | 1 |
| Crittenden, DB; Fisher, MC; Jeurling, S; Katz, SD; Krasnokutsky, S; Pike, VC; Pillinger, MH; Shah, B; Slobodnick, A; Tenner, CT; Toprover, M; Xia, Y | 1 |
| Fischman, D; Gowda, SN; Ullah, W | 1 |
| Samuel, M; Waters, DD | 1 |
| Adler, Y; Andreis, A; Brucato, A; De Ferrari, GM; Imazio, M | 1 |
| Abusnina, W; Al-Abdouh, A; Barbarawi, M; Khan, SU; Michos, ED; Osman, M; Radaideh, Q; Solipuram, V; Upadhrasta, S; Zhao, D | 1 |
| Bax, WA; Cornel, JH; de Kleijn, D; Fiolet, ATL; Mosterd, A; Opstal, TSJ; Silvis, MJM; van der Horst, FAL | 1 |
| Fernández-Ruiz, I | 1 |
| Butt, AK; Cave, B; Khouzam, RN; Maturana, M; Towers, WF | 1 |
| Liuzzo, G; Patrono, C | 1 |
| Aimo, A; Barison, A; Bayes-Genis, A; Cediel, G; Emdin, M; Pascual-Figal, DA; Saccaro, LF; Vicente, ÁH | 1 |
| Qian, C; Xia, M; Yang, X | 1 |
| Roubille, F; Tardif, JC | 1 |
| Aimo, A; Bayes-Genis, A; Emdin, M; Georgiopoulos, G; Pascual Figal, DA | 1 |
| Crea, F; D'Amario, D; Galli, M; Princi, G | 2 |
| Huang, HK; Shih, MC; Tien, YY; Tu, YK | 1 |
| Nicholls, M | 1 |
| Cornel, JH; Fiolet, ATL; Nidorf, SM | 1 |
| Cohn, JN | 1 |
| Nabavizadeh, P; Steen, DL | 1 |
| Figtree, G; Galougahi, KK; Kurup, R; Misra, A; Patel, S | 1 |
| Blondeau, L; Bouabdallaoui, N; Tardif, JC | 1 |
| Angelini, F; Bocchino, PP; Imazio, M | 1 |
| Koenig, W; Nitschmann, S | 1 |
| Afework, Y; Anders, NM; Bagchi, S; Barditch-Crovo, P; Bonanno, G; Gerstenblith, G; Hays, AG; Kelly, S; Lai, S; Margolick, JB; Meyer, J; Schär, M; Stradley, S; Streeb, V; Weiss, RG | 1 |
| Abel, D; Ardoin, SP; Gorelik, M | 1 |
| Jackson, CD; Kaiser, D | 1 |
| Gebhard, C; Regitz-Zagrosek, V | 1 |
| Fischer, BG | 1 |
| Javor, E; Lucijanic, M; Skelin, M | 1 |
| D'Amario, D; Galli, M; Rodolico, D | 1 |
| Cornel, JH; Fiolet, ATL; Thompson, PL | 1 |
| Bates, ER | 1 |
| Budgeon, C; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP | 1 |
| Arcudi, A; Borovac, JA; Cappannoli, L; Cappetta, D; Chouchane, K; Crea, F; D'Amario, D; De Angelis, A; Diana, G; Galli, M; Liuzzo, G; Migliaro, S; Montone, RA; Princi, G; Restivo, A; Vergallo, R | 1 |
| Budgeon, C; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Jolly, SS; Keech, AC; Kelly, P; Layland, J; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; Tong, DC | 1 |
| Andreis, A; Avondo, S; Casula, M; De Ferrari, GM; Imazio, M; Paneva, E; Piroli, F | 1 |
| Katira, A; Katira, R | 1 |
| Pradhan, AD | 1 |
| Banach, M; Penson, PE | 1 |
| Ebell, MH | 1 |
| Chai, P; Chan, MY; Goh, MW; Lee, CH; Sia, CH; Syn, NL; Teo, YH; Teo, YN; Yeo, TC; Yoong, CSY | 1 |
| Alam, M; Fischman, DL; Gowda, SN; Hamzeh, I; Haq, S; Ottman, P; Saleem, S; Ullah, W; Virani, SS; Zahid, S | 1 |
| Alkhalil, M; Ibrahem, A; Kuzemczak, M | 1 |
| Sudevan, R | 1 |
| Hota, D; Maiti, R; Sethuramalingam, S; Srinivasan, A | 1 |
| Bajraktari, G; Banach, M; Bytyçi, I; Henein, MY; Penson, PE | 1 |
| Anderson, TJ; Bell, AD; Bewick, D; Cox, J; Goodman, SG; Grégoire, JC; Gupta, A; Huynh, T; Kertland, H; Kouz, S; L'Allier, PL; Madan, M; Mancini, GBJ; Marquis-Gravel, G; McPherson, R; So, DYF; Tardif, JC; Welsh, RC; Wong, G | 1 |
| Alcock, R; Barlis, P; Butters, J; Dautov, R; Di Giovanni, G; Montarello, NJ; Nerlekar, N; Nicholls, SJ; Nidorf, SM; Ottaway, JL; Patel, S; Psaltis, PJ; Rajendran, S; Salagaras, T; Singh, K; Sinhal, A; Thompson, PL; Wong, DTL | 1 |
| Marquis-Gravel, G; Tardif, JC | 1 |
| Lafferty, J; O'Herron, T | 1 |
| Ashish, K; Bandyopadhyay, D; Ghosh, RK; Mondal, S | 1 |
| Akodad, M; Fauconnier, J; Lacampagne, A; Roubille, F | 1 |
| Martínez, G; Patel, S; Vaidya, K | 1 |
| Cornel, JH; Fiolet, ATL; Mosterd, A; Nidorf, SM | 1 |
| Chatzidou, S; Iliopoulos, DC; Kaminiotis, VV; Kontogiannis, C; Moris, D; Paschou, SA; Siasos, G; Spartalis, E; Spartalis, M; Tsilimigras, DI; Tzatzaki, E; Voudris, V | 1 |
| Nidorf, SM; Thompson, PL | 1 |
| Higashi, Y; Kajikawa, M; Kihara, Y; Kurisu, S; Maruhashi, T; Mutoh, A; Tomiyama, H; Ueda, SI | 1 |
| Cleman, MW; Deftereos, S; Giannopoulos, G; Kossyvakis, C; Panagopoulou, V; Papoutsidakis, N; Raisakis, K; Stefanadis, C | 1 |
| Eikelboom, JW; Nidorf, SM; Thompson, PL | 1 |
| Nidorf, SM; Verma, S | 1 |
| Barraclough, J; Bursill, C; Celermajer, DS; Mallat, Z; Martínez, GJ; Patel, S; Robertson, S; Xia, Q | 1 |
| Angelidis, C; Cleman, MW; Deftereos, S; Giannopoulos, G; Lekakis, J; Panagopoulou, V; Papoutsidakis, N | 1 |
| Nidorf, M; Thompson, PL | 1 |
| Bauriedel, G; Beinert, T; Heimerl, J; Höfling, B; Welsch, U | 1 |
| Bauriedel, G; Gonschior, P; Heimerl, J; Höfling, B; Welsch, U | 1 |
48 review(s) available for colchicine and Coronary Artery Disease
| Article | Year |
|---|---|
Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Drug Interactions; Humans; Myocardial Infarction | 2021 |
Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Stroke | 2022 |
Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review.
Topics: Alcohol Drinking; Anticoagulants; Antihypertensive Agents; Cholesterol Ester Transfer Proteins; Colchicine; Coronary Artery Disease; Coronary Vessels; Diagnostic Imaging; Diet; Eicosapentaenoic Acid; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Plaque, Atherosclerotic; Smoking Cessation | 2022 |
Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention.
Topics: Colchicine; Coronary Artery Disease; Humans; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Complications; Tubulin Modulators | 2022 |
Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2022 |
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
Topics: Anti-Inflammatory Agents; Cardiovascular Agents; Colchicine; Coronary Artery Disease; COVID-19 Drug Treatment; Humans; Myocardial Infarction | 2022 |
Comment on "Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials".
Topics: Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2022 |
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Ischemic Stroke; Myocardial Infarction; Randomized Controlled Trials as Topic | 2022 |
The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myalgia; Stroke | 2022 |
Effect of colchicine on inflammatory markers in patients with coronary artery disease: A meta-analysis of clinical trials.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Interleukin-6 | 2022 |
Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2022 |
Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Percutaneous Coronary Intervention | 2023 |
Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients With Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke | 2023 |
A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Artery Bypass; Coronary Artery Disease; Humans; Percutaneous Coronary Intervention; Pneumonia; Treatment Outcome | 2023 |
Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Colchicine; Coronary Artery Disease; Drug Repositioning; Gout; Humans; Secondary Prevention; Symptom Flare Up | 2023 |
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
Topics: Adult; Atherosclerosis; Cholesterol, LDL; Colchicine; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Myocardial Infarction; Secondary Prevention | 2023 |
Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Secondary Prevention; Stroke | 2020 |
Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Artery Disease; Humans; Stents; Stroke | 2021 |
Colchicine for acute and chronic coronary syndromes.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Coronary Artery Disease; Humans; Treatment Outcome | 2020 |
Colchicine therapy in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2021 |
The Role of Colchicine in Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Clinical Trials, Phase III as Topic; Colchicine; Coronary Artery Disease; Humans; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic | 2021 |
Colchicine for the treatment of coronary artery disease.
Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
Topics: Colchicine; Coronary Artery Disease; Humans; Prognosis; Secondary Prevention; Tubulin Modulators | 2021 |
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
Topics: Acute Coronary Syndrome; Angina Pectoris; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Myocardial Infarction; Proportional Hazards Models | 2021 |
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Drug Repositioning; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Treatment Outcome | 2021 |
The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Colchicine; Coronary Artery Disease; Humans; Plaque, Atherosclerotic | 2021 |
The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.
Topics: Age of Onset; Child; Colchicine; Coronary Artery Disease; Heart Disease Risk Factors; Humans; Lupus Erythematosus, Systemic; Protective Agents | 2021 |
Colchicine in ischemic heart disease: the good, the bad and the ugly.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Inflammation; Myocardial Ischemia; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic | 2021 |
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2021 |
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention; Stroke | 2022 |
Colchicine in coronary artery disease.
Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2022 |
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans | 2021 |
Colchicine Reduces MI and Revascularization in Patients with Established Coronary Artery Disease.
Topics: Colchicine; Coronary Artery Disease; Global Health; Humans; Incidence; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Factors; Treatment Outcome; Tubulin Modulators | 2021 |
Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Tubulin Modulators | 2021 |
Safety and Efficacy of Colchicine in Patients with Stable CAD and ACS: A Systematic Review and Meta-analysis.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Artery Disease; Humans | 2021 |
Colchicine in Patients with Coronary Artery Disease with or Without Diabetes Mellitus: A Meta-analysis of Randomized Clinical Trials.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Diabetes Mellitus; Humans; Randomized Controlled Trials as Topic | 2021 |
Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Heart Disease Risk Factors; Humans; Inflammation; Myocardial Infarction; Risk Factors | 2023 |
Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Topics: C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2022 |
Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
Topics: Colchicine; Coronary Artery Disease; Gout Suppressants; Humans; Peripheral Arterial Disease; Plaque, Atherosclerotic | 2021 |
The Role of Colchicine in Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Cytokines; Humans; Inflammation; Monocytes | 2019 |
Colchicine in Stable Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Gout; Humans; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention | 2019 |
The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic | 2018 |
Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Cytokines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Secondary Prevention | 2019 |
Colchicine and the heart: pushing the envelope.
Topics: Angioplasty; Animals; Atrial Fibrillation; Colchicine; Coronary Artery Disease; Heart Diseases; Humans; Pericarditis; Tubulin Modulators | 2013 |
Colchicine for secondary prevention of cardiovascular disease.
Topics: Acute Coronary Syndrome; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Secondary Prevention; Time; Treatment Outcome | 2014 |
Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
Topics: Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colchicine; Coronary Artery Disease; Cytochrome P-450 CYP3A; Humans; Microtubules | 2015 |
10 trial(s) available for colchicine and Coronary Artery Disease
| Article | Year |
|---|---|
Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
Topics: Adult; Aged; Aged, 80 and over; Colchicine; Coronary Artery Disease; Female; Humans; Male; Middle Aged | 2022 |
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial.
Topics: Aged; Biomarkers; Colchicine; Coronary Artery Disease; Creatine Kinase; Creatinine; Female; Humans; Kidney; Liver; Male | 2022 |
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Australia; Cardiovascular Diseases; Clinical Trial Protocols as Topic; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Repositioning; Female; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Secondary Prevention; Stroke; Tubulin Modulators | 2019 |
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; New York City; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome | 2020 |
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
Topics: Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Colchicine; Coronary Artery Disease; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Inflammation; Leukocyte Count; Lipid Metabolism; Male; Middle Aged; Platelet Count; Prospective Studies; Treatment Outcome | 2020 |
A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
Topics: Colchicine; Coronary Artery Disease; Double-Blind Method; Hand Strength; HIV Infections; Humans | 2021 |
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Tomography, Optical Coherence | 2022 |
Effect of short-term colchicine treatment on endothelial function in patients with coronary artery disease.
Topics: Aged; Colchicine; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Gout Suppressants; Humans; Male; Middle Aged; Treatment Outcome; Ultrasonography, Interventional | 2019 |
Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Anti-Inflammatory Agents; Biomarkers; Colchicine; Coronary Artery Disease; Coronary Sinus; Cytokines; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Humans; Inflammation Mediators; Interleukin-18; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Myocardium; New South Wales; Time Factors; Treatment Outcome | 2015 |
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
Topics: Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Colchicine; Coronary Angiography; Coronary Artery Disease; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Pyrroles; Treatment Outcome | 2007 |
50 other study(ies) available for colchicine and Coronary Artery Disease
| Article | Year |
|---|---|
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
Topics: Biomarkers; Colchicine; Coronary Artery Disease; Extracellular Vesicles; Humans; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein | 2021 |
Repurposing Colchicine for Heart Disease.
Topics: Atrial Fibrillation; Colchicine; Coronary Artery Disease; Humans; Inflammation; Pericarditis | 2022 |
Anti-inflammatory strategies for atherosclerotic artery disease.
Topics: Anti-Inflammatory Agents; Arteries; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Inflammation | 2022 |
Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors.
Topics: Cilostazol; Colchicine; Coronary Artery Disease; Cyclic AMP; Diabetes Mellitus, Type 2; Humans; Muscle, Smooth, Vascular; Sirolimus; Tetrazoles; Vascular Diseases | 2022 |
Anti-inflammatory Drug Combination Therapy for Atherosclerosis:\
Colchicine and Fenofibrate
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Drug Combinations; Fenofibrate; Humans | 2022 |
Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease.
Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2022 |
[Research progress of colchicine in the prevention and treatment of coronary heart disease].
Topics: Colchicine; Coronary Artery Disease; Coronary Disease; Humans; Plaque, Atherosclerotic | 2022 |
Colchicine may decrease cardiovascular events in patients with coronary artery disease.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans | 2022 |
Colchicine and Acute Coronary Syndromes: A New Trick for an Old Drug?
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans | 2022 |
Association between tissue human neutrophil peptide 1-3 levels and cardiovascular phenotype: a prospective, longitudinal cohort study.
Topics: alpha-Defensins; Atherosclerosis; Cohort Studies; Colchicine; Coronary Artery Disease; Humans; Longitudinal Studies; Phenotype; Plaque, Atherosclerotic; Prospective Studies; Risk Factors | 2022 |
Could colchicine reduce cardiovascular events in coronary artery disease without increasing all-cause mortality: Avoid optical illusions!
Topics: Colchicine; Coronary Artery Disease; Humans; Optical Illusions | 2023 |
Successful treatment of two cases of acute myocarditis with colchicine.
Topics: Adult; Colchicine; Coronary Artery Disease; Familial Mediterranean Fever; Humans; Myocarditis; Pericarditis | 2023 |
Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Inflammation; Secondary Prevention | 2023 |
We never speak about sudden unexpected death in Parkinson's disease.
Topics: Colchicine; Coronary Artery Disease; Death, Sudden; Humans; Parkinson Disease; Stroke | 2020 |
Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Anticholesteremic Agents; Cholesterol, LDL; Colchicine; Combined Modality Therapy; Coronary Artery Disease; Humans; Hypercholesterolemia; Inflammation; Myocardial Infarction; RNA, Small Interfering | 2020 |
Colchicine prevents stroke in patients with coronary artery disease - a trial sequential analysis.
Topics: Colchicine; Coronary Artery Disease; Humans; Stroke | 2020 |
Optimization of stroke prevention: colchicine may be an option.
Topics: Colchicine; Coronary Artery Disease; Humans; Stroke | 2020 |
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?
Topics: Colchicine; Coronary Artery Disease; Humans; Inflammation; Percutaneous Coronary Intervention | 2020 |
Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
Topics: Colchicine; Coronary Angiography; Coronary Artery Disease; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; United States | 2020 |
Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
Topics: Cardiovascular System; Colchicine; Coronary Artery Disease; Gout; Humans; Male; Secondary Prevention | 2020 |
Low-dose colchicine shows promise in chronic coronary disease.
Topics: Colchicine; Coronary Artery Disease; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2020 |
Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2020 |
Editorial commentary: Embracing colchicine as a new cornerstone therapy for coronary disease.
Topics: Colchicine; Coronary Artery Disease; Humans | 2021 |
Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2020 |
Australia and colchicine for coronary heart disease.
Topics: Australia; Colchicine; Coronary Artery Disease; Humans | 2021 |
Colchicine for secondary prevention in coronary disease.
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Highlights from the European society of cardiology congress 2020.
Topics: Atrial Fibrillation; Benzhydryl Compounds; Benzylamines; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Europe; Glucosides; Heart Failure; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Societies, Medical; Sodium-Glucose Transporter 2 Inhibitors; Tubulin Modulators; Uracil | 2021 |
Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention | 2021 |
Colchicine and coronary artery disease: a virtuous adoption.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans | 2021 |
[Colchicine in patients with coronary heart disease : LoDoCo2 trial].
Topics: Colchicine; Coronary Artery Disease; Gout Suppressants; Humans; Secondary Prevention; Tubulin Modulators | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease. Reply.
Topics: Anti-Inflammatory Agents; Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
Topics: Cardiovascular Diseases; Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2021 |
Low-dose colchicine for coronary artery disease.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Treatment Outcome | 2021 |
Is there a role for colchicine in secondary prevention of coronary artery disease?
Topics: Colchicine; Coronary Artery Disease; Humans; Secondary Prevention | 2022 |
Low-Dose Colchicine for the Management of Coronary Artery Disease.
Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Prophylactic use of colchicine in preventing radiation induced coronary artery disease.
Topics: Anti-Inflammatory Agents; Blood Platelets; Breast Neoplasms; Colchicine; Coronary Artery Disease; Female; Humans; Inflammation; Mediastinum; Microtubules; Models, Theoretical; Plaque, Atherosclerotic; Platelet Aggregation; Radiation Injuries; Radiotherapy | 2018 |
Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans | 2018 |
Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Colchicine; Coronary Artery Disease; Humans | 2018 |
Is There a Role for Colchicine in Acute Coronary Syndromes?
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Cytokines; Female; Humans; Inflammation Mediators; Male; Myocardium | 2015 |
Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy.
Topics: Actin Cytoskeleton; Actins; Arteriosclerosis; Atherectomy; Atherectomy, Coronary; Cell Division; Cell Membrane; Cell Movement; Cells, Cultured; Colchicine; Coronary Artery Disease; Humans; Microscopy, Electron; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microtubules; Muscle, Smooth, Vascular; Organelles; Video Recording | 1994 |
Analysis of atherectomy specimens.
Topics: Animals; Arteriosclerosis; Atherectomy; Atherectomy, Coronary; Cells, Cultured; Colchicine; Coronary Artery Disease; Coronary Vessels; Humans; Microscopy, Electron; Muscle, Smooth, Vascular; Recurrence; Swine; Swine, Miniature; Tunica Intima | 1993 |